190 related articles for article (PubMed ID: 21951539)
1. Zebrafish models of rhabdomyosarcoma.
Chen EY; Langenau DM
Methods Cell Biol; 2011; 105():383-402. PubMed ID: 21951539
[TBL] [Abstract][Full Text] [Related]
2. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.
Liu S; Leach SD
Methods Cell Biol; 2011; 105():367-81. PubMed ID: 21951538
[TBL] [Abstract][Full Text] [Related]
3. Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
Langenau DM; Keefe MD; Storer NY; Guyon JR; Kutok JL; Le X; Goessling W; Neuberg DS; Kunkel LM; Zon LI
Genes Dev; 2007 Jun; 21(11):1382-95. PubMed ID: 17510286
[TBL] [Abstract][Full Text] [Related]
4. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish.
Langenau DM; Keefe MD; Storer NY; Jette CA; Smith AC; Ceol CJ; Bourque C; Look AT; Zon LI
Oncogene; 2008 Jul; 27(30):4242-8. PubMed ID: 18345029
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.
Park SW; Davison JM; Rhee J; Hruban RH; Maitra A; Leach SD
Gastroenterology; 2008 Jun; 134(7):2080-90. PubMed ID: 18549880
[TBL] [Abstract][Full Text] [Related]
7. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma.
Martinelli S; McDowell HP; Vigne SD; Kokai G; Uccini S; Tartaglia M; Dominici C
Genes Chromosomes Cancer; 2009 Nov; 48(11):975-82. PubMed ID: 19681119
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis.
Storer NY; White RM; Uong A; Price E; Nielsen GP; Langenau DM; Zon LI
Development; 2013 Jul; 140(14):3040-50. PubMed ID: 23821038
[TBL] [Abstract][Full Text] [Related]
9. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent imaging of cancer in zebrafish.
Ignatius MS; Langenau DM
Methods Cell Biol; 2011; 105():437-59. PubMed ID: 21951542
[TBL] [Abstract][Full Text] [Related]
11. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
[TBL] [Abstract][Full Text] [Related]
12.
Ignatius MS; Hayes MN; Moore FE; Tang Q; Garcia SP; Blackburn PR; Baxi K; Wang L; Jin A; Ramakrishnan A; Reeder S; Chen Y; Nielsen GP; Chen EY; Hasserjian RP; Tirode F; Ekker SC; Langenau DM
Elife; 2018 Sep; 7():. PubMed ID: 30192230
[TBL] [Abstract][Full Text] [Related]
13. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.
Nishimura R; Takita J; Sato-Otsubo A; Kato M; Koh K; Hanada R; Tanaka Y; Kato K; Maeda D; Fukayama M; Sanada M; Hayashi Y; Ogawa S
Cancer Sci; 2013 Jul; 104(7):856-64. PubMed ID: 23578105
[TBL] [Abstract][Full Text] [Related]
14. Zebrafish Rhabdomyosarcoma.
Phelps M; Chen E
Adv Exp Med Biol; 2016; 916():371-89. PubMed ID: 27165362
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations.
Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412
[TBL] [Abstract][Full Text] [Related]
16. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.
Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM
Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271
[TBL] [Abstract][Full Text] [Related]
17. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
[TBL] [Abstract][Full Text] [Related]
18. Childhood rhabdomyosarcoma: new insight on biology and treatment.
Huh WW; Skapek SX
Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958
[TBL] [Abstract][Full Text] [Related]
19. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
[TBL] [Abstract][Full Text] [Related]
20. Lessons from transgenic zebrafish expressing the green fluorescent protein (GFP) in the myeloid lineage.
Hsu K; Look AT; Kanki JP
Methods Cell Biol; 2004; 77():333-47. PubMed ID: 15602920
[No Abstract] [Full Text] [Related]
[Next] [New Search]